The role of nuclear antiviral factors against invading DNA viruses: The immediate fate of incoming viral genomes

Viruses

Volumn 8, Issue 10, 2016, Pages

  Komatsu, Tetsuro ^a,b   Nagata, Kyosuke ^b   Wodrich, Harald ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adenovirus; Antiviral response; Herpesvirus; IFI16; Incoming viral genomes; Intrinsic immunity; PML nuclear body

Indexed keywords

SUMO 2 PROTEIN; DNA VIRUS;

BIOCHEMICAL ANALYSIS; CHROMATIN IMMUNOPRECIPITATION; DNA REPLICATION; DNA VIRUS INFECTION; GENE EXPRESSION; GENE SILENCING; HERPES SIMPLEX VIRUS; HUMAN ADENOVIRUS 1; IMMUNOFLUORESCENCE TEST; PLASMID; PROMYELOCYTIC LEUKEMIA; REVIEW; SIGNAL TRANSDUCTION; VIRUS GENOME; ANIMAL; CELL NUCLEUS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL NUCLEUS; DNA VIRUSES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE;

EID: 84992747009     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8100290     Document Type: Review

References (105)

1. Pandey, S.; Kawai, T.; Akira, S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb. Perspect. Biol. 2015, 7, a016246. [CrossRef] [PubMed]
2. Cai, X.; Chiu, Y.-H.; Chen, Z.J. The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling. Molecular Cell 2014, 54, 289-296. [CrossRef] [PubMed]
3. Chan, Y.K.; Gack, M.U. Viral evasion of intracellular DNA and RNA sensing. Nat. Immunol. 2016, 14, 360-373. [CrossRef] [PubMed]
4. Orzalli, M.H.; Knipe, D.M. Cellular Sensing of Viral DNA and Viral Evasion Mechanisms. Annu. Rev. Microbiol. 2014, 68, 477-492. [CrossRef] [PubMed]
5. Everett, R.D. The Spatial Organization of DNA Virus Genomes in the Nucleus. PLoS Pathog. 2013, 9, e1003386. [CrossRef] [PubMed]
6. Tavalai, N.; Stamminger, T. Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies. Viruses 2009, 1, 1240-1264. [CrossRef] [PubMed]
7. Bieniasz, P.D. Intrinsic immunity: A front-line defense against viral attack. Nat. Immunol. 2004, 5, 1109-1115. [CrossRef] [PubMed]
8. Yan, N.; Chen, Z.J. Intrinsic antiviral immunity. Nat. Immunol. 2012, 13, 214-222. [CrossRef] [PubMed]
9. Lallemand-Breitenbach, V.; De Thé, H. PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2010, 2, a000661. [CrossRef] [PubMed]
10. Ching, R.W.; Dellaire, G.; Eskiw, C.H.; Bazett-Jones, D.P. PML bodies: A meeting place for genomic loci? J. Cell Sci. 2005, 118, 847-854. [CrossRef] [PubMed]
11. Shen, T.H.; Lin, H.-K.; Scaglioni, P.P.; Yung, T.M.; Pandolfi, P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 2006, 24, 331-339. [CrossRef] [PubMed]
12. Ishov, A.M.; Sotnikov, A.G.; Negorev, D.; Vladimirova, O.V.; Neff, N.; Kamitani, T.; Yeh, E.T.; Strauss, J.F.; Maul, G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 1999, 147, 221-234. [CrossRef] [PubMed]
13. Sternsdorf, T.; Jensen, K.; Reich, B.; Will, H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 1999, 274, 12555-12566. [CrossRef] [PubMed]
14. Negorev, D.G.; Vladimirova, O.V.; Ivanov, A.; Rauscher, F.; Maul, G.G. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. 2006, 80, 8019-8029. [CrossRef] [PubMed]
15. Xue, Y.; Gibbons, R.; Yan, Z.; Yang, D.; McDowell, T.L.; Sechi, S.; Qin, J.; Zhou, S.; Higgs, D.; Wang, W. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl. Acad. Sci. USA 2003, 100, 10635-10640. [CrossRef] [PubMed]
16. Goldberg, A.D.; Banaszynski, L.A.; Noh, K.-M.; Lewis, P.W.; Elsaesser, S.J.; Stadler, S.; Dewell, S.; Law, M.; Guo, X.; Li, X.; et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 2010, 140, 678-691. [CrossRef] [PubMed]
17. Li, H.; Leo, C.; Zhu, J.; Wu, X.; O’Neil, J.; Park, E.J.; Chen, J.D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 2000, 20, 1784-1796. [CrossRef] [PubMed]
18. Hollenbach, A.D.; McPherson, C.J.; Mientjes, E.J.; Iyengar, R.; Grosveld, G. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 2002, 115, 3319-3330. [PubMed]
19. Puto, L.A.; Reed, J.C. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev. 2008, 22, 998-1010. [CrossRef] [PubMed]
20. Grötzinger, T.; Sternsdorf, T.; Jensen, K.; Will, H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 1996, 238, 554-560. [CrossRef] [PubMed]
21. Gongora, R.; Stephan, R.P.; Zhang, Z.; Cooper, M.D. An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. Immunity 2001, 14, 727-737.[CrossRef]
22. Unterholzner, L.; Keating, S.E.; Baran, M.; Horan, K.A.; Jensen, S.B.; Sharma, S.; Sirois, C.M.; Jin, T.; Latz, E.; Xiao, T.S.; et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11, 997-1004. [CrossRef] [PubMed]
23. Cuchet-Lourenco, D.; Anderson, G.; Sloan, E.; Orr, A.; Everett, R.D. The Viral Ubiquitin Ligase ICP0 Is neither Sufficient nor Necessary for Degradation of the Cellular DNA Sensor IFI16 during Herpes Simplex Virus 1 Infection. J. Virol. 2013, 87, 13422-13432. [CrossRef] [PubMed]
24. Everett, R.D. Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection. J. Virol. 2016, 90, 167-179. [CrossRef] [PubMed]
25. Scherer, M.; Stamminger, T. Emerging Role of PML Nuclear Bodies in Innate Immune Signaling. J. Virol. 2016, 90, 5850-5854. [CrossRef] [PubMed]
26. Komatsu, T.; Nagata, K.; Wodrich, H. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies. J. Virol. 2016, 90, 1657-1667. [CrossRef] [PubMed]
27. Komatsu, T.; Will, H.; Nagata, K.; Wodrich, H. Imaging analysis of nuclear antiviral factors through direct detection of incoming adenovirus genome complexes. Biochem. Biophys. Res. Commun. 2016, 1-6. [CrossRef] [PubMed]
28. Mundade, R.; Ozer, H.G.; Wei, H.; Prabhu, L.; Lu, T. Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond. Cell Cycle 2014, 13, 2847-2852. [CrossRef] [PubMed]
29. Wang, I.-H.; Suomalainen, M.; Andriasyan, V.; Kilcher, S.; Mercer, J.; Neef, A.; Luedtke, N.W.; Greber, U.F. Tracking Viral Genomes in Host Cells at Single-Molecule Resolution. Cell Host Microbe 2013, 14, 468-480. [CrossRef] [PubMed]
30. Dembowski, J.A.; DeLuca, N.A. Selective Recruitment of Nuclear Factors to Productively Replicating Herpes Simplex Virus Genomes. PLoS Pathog. 2015, 11, e1004939. [CrossRef] [PubMed]
31. Broniarczyk, J.; Massimi, P.; Bergant, M.; Banks, L. Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process. J. Virol. 2015, 89, 8727-8732. [CrossRef] [PubMed]
32. Bund, T.; Spoden, G.A.; Koynov, K.; Hellmann, N.; Boukhallouk, F.; Arnold, P.; Hinderberger, D.; Florin, L. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. Cell Microbiol. 2014, 16, 1179-1200. [CrossRef] [PubMed]
33. Ishov, A.M.; Maul, G.G. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 1996, 134, 815-826. [CrossRef] [PubMed]
34. Ishov, A.M.; Stenberg, R.M.; Maul, G.G. Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment. J. Cell Biol. 1997, 138, 5-16. [CrossRef] [PubMed]
35. Everett, R.D.; Sourvinos, G.; Orr, A. Recruitment of Herpes Simplex Virus Type 1 Transcriptional Regulatory Protein ICP4 into Foci Juxtaposed to ND10 in Live, Infected Cells. J. Virol. 2003, 77, 3680-3689. [CrossRef] [PubMed]
36. Everett, R.D.; Sourvinos, G.; Leiper, C.; Clements, J.B.; Orr, A. Formation of Nuclear Foci of the Herpes Simplex Virus Type 1 Regulatory Protein ICP4 at Early Times of Infection: Localization, Dynamics, Recruitment of ICP27, and Evidence for the De Novo Induction of ND10-Like Complexes. J. Virol. 2004, 78, 1903-1917. [CrossRef] [PubMed]
37. Everett, R.D.; Murray, J. ND10 Components Relocate to Sites Associated with Herpes Simplex Virus Type 1 Nucleoprotein Complexes during Virus Infection. J. Virol. 2005, 79, 5078-5089. [CrossRef] [PubMed]
38. Boutell, C.; Everett, R.D. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. General Virol. 2013, 94, 465-481. [CrossRef] [PubMed]
39. Everett, R.D.; Rechter, S.; Papior, P.; Tavalai, N.; Stamminger, T.; Orr, A. PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0. J. Virol. 2006, 80, 7995-8005. [CrossRef] [PubMed]
40. Everett, R.D.; Parada, C.; Gripon, P.; Sirma, H.; Orr, A. Replication of ICP0-Null Mutant Herpes Simplex Virus Type 1 Is Restricted by both PML and Sp100. J. Virol. 2008, 82, 2661-2672. [CrossRef] [PubMed]
41. Lukashchuk, V.; Everett, R.D. Regulation of ICP0-Null Mutant Herpes Simplex Virus Type 1 Infection by ND10 Components ATRX and hDaxx. J. Virol. 2010, 84, 4026-4040. [CrossRef] [PubMed]
42. Chee, A.V.; Lopez, P.; Pandolfi, P.P.; Roizman, B. Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects. J. Virol. 2003, 77, 7101-7105. [CrossRef] [PubMed]
43. Diner, B.A.; Li, T.; Greco, T.M.; Crow, M.S.; Fuesler, J.A.; Wang, J.; Cristea, I.M. The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. Mol. Syst. Biol. 2015, 11, 787. [CrossRef] [PubMed]
44. Cuchet-Lourenço, D.; Boutell, C.; Lukashchuk, V.; Grant, K.; Sykes, A.; Murray, J.; Orr, A.; Everett, R.D. SUMO Pathway Dependent Recruitment of Cellular Repressors to Herpes Simplex Virus Type 1 Genomes. PLoS Pathog. 2011, 7, e1002123. [CrossRef] [PubMed]
45. Gariano, G.R.; Dell’Oste, V.; Bronzini, M.; Gatti, D.; Luganini, A.; De Andrea, M.; Gribaudo, G.; Gariglio, M.; Landolfo, S. The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication. PLoS Pathog. 2012, 8, e1002498. [CrossRef] [PubMed]
46. Johnson, K.E.; Bottero, V.; Flaherty, S.; Dutta, S.; Singh, V.V.; Chandran, B. IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications. PLoS Pathog. 2014, 10, e1004503. [CrossRef] [PubMed]
47. Orzalli, M.H.; Conwell, S.E.; Berrios, C.; DeCaprio, J.A.; Knipe, D.M. Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc. Natl. Acad. Sci. USA 2013, 110, E4492-E4501. [CrossRef] [PubMed]
48. Orzalli, M.H.; DeLuca, N.A.; Knipe, D.M. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. USA 2012, 109, E3008-E3017. [CrossRef] [PubMed]
49. Diner, B.A.; Lum, K.K.; Javitt, A.; Cristea, I.M. Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression. Mol. Cell Proteomics 2015, 14, 2341-2356. [CrossRef] [PubMed]
50. Orzalli, M.H.; Broekema, N.M.; Knipe, D.M. Relative Contributions of Herpes Simplex Virus 1 ICP0 and vhs to Loss of Cellular IFI16 Vary in Different Human Cell Types. J. Virol. 2016, 90, 8351-8359. [CrossRef] [PubMed]
51. Li, T.; Diner, B.A.; Chen, J.; Cristea, I.M. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc. Natl. Acad. Sci. USA 2012, 109, 10558-10563. [CrossRef] [PubMed]
52. Orzalli, M.H.; Broekema, N.M.; Diner, B.A.; Hancks, D.C.; Elde, N.C.; Cristea, I.M.; Knipe, D.M. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc. Natl. Acad. Sci. USA 2015, 112, E1773-E1781. [CrossRef] [PubMed]
53. Sourvinos, G.; Tavalai, N.; Berndt, A.; Spandidos, D.A.; Stamminger, T. Recruitment of Human Cytomegalovirus Immediate-Early 2 Protein onto Parental Viral Genomes in Association with ND10 in Live-Infected Cells. J. Virol. 2007, 81, 10123-10136. [CrossRef] [PubMed]
54. Tavalai, N.; Papior, P.; Rechter, S.; Leis, M.; Stamminger, T. Evidence for a Role of the Cellular ND10 Protein PML in Mediating Intrinsic Immunity against Human Cytomegalovirus Infections. J. Virol. 2006, 80, 8006-8018. [CrossRef] [PubMed]
55. Müller, S.; Dejean, A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 1999, 73, 5137-5143. [PubMed]
56. Everett, R.D.; Bell, A.J.; Lu, Y.; Orr, A. The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71. J. Virol. 2013, 87, 978-990. [CrossRef] [PubMed]
57. Hofmann, H.; Sindre, H.; Stamminger, T. Functional Interaction between the pp71 Protein of Human Cytomegalovirus and the PML-Interacting Protein Human Daxx. J. Virol. 2002, 76, 5769-5783. [CrossRef] [PubMed]
58. Saffert, R.T.; Kalejta, R.F. Inactivating a Cellular Intrinsic Immune Defense Mediated by Daxx Is the Mechanism through Which the Human Cytomegalovirus pp71 Protein Stimulates Viral Immediate-Early Gene Expression. J. Virol. 2006, 80, 3863-3871. [CrossRef] [PubMed]
59. Lukashchuk, V.; McFarlane, S.; Everett, R.D.; Preston, C.M. Human Cytomegalovirus Protein pp71 Displaces the Chromatin-Associated Factor ATRX from Nuclear Domain 10 at Early Stages of Infection. J. Virol. 2008, 82, 12543-12554. [CrossRef] [PubMed]
60. Full, F.; Jungnickl, D.; Reuter, N.; Bogner, E.; Brulois, K.; Scholz, B.; Stürzl, M.; Myoung, J.; Jung, J.U.; Stamminger, T. et al. Kaposi’s sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. PLoS Pathog. 2014, 10, e1003863. [CrossRef] [PubMed]
61. Tsai, K.; Thikmyanova, N.; Wojcechowskyj, J.A.; Delecluse, H.-J.; Lieberman, P.M. EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription. PLoS Pathog. 2011, 7, e1002376. [CrossRef] [PubMed]
62. Schreiner, S.; Wodrich, H. Virion Factors That Target Daxx To Overcome Intrinsic Immunity. J. Virol. 2013, 87, 10412-10422. [CrossRef] [PubMed]
63. Lu, Y.; Orr, A.; Everett, R.D. Stimulation of the replication of ICP0-null mutant HSV-1 and pp71-deficient HCMV by EBV tegument protein BNRF1. J. Virol. 2016. [CrossRef] [PubMed]
64. Tavalai, N.; Papior, P.; Rechter, S.; Stamminger, T. Nuclear Domain 10 Components Promyelocytic Leukemia Protein and hDaxx Independently Contribute to an Intrinsic Antiviral Defense against Human Cytomegalovirus Infection. J. Virol. 2008, 82, 126-137. [CrossRef] [PubMed]
65. Adler, M.; Tavalai, N.; Muller, R.; Stamminger, T. Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J. General Virol. 2011, 92, 1532-1538. [CrossRef] [PubMed]
66. Li, T.; Chen, J.; Cristea, I.M. Human Cytomegalovirus Tegument Protein pUL83 Inhibits IFI16-Mediated DNA Sensing for Immune Evasion. Cell Host Microbe 2013, 14, 591-599.
67. Dell’Oste, V.; Gatti, D.; Gugliesi, F.; De Andrea, M.; Bawadekar, M.; Lo Cigno, I.; Biolatti, M.; Vallino, M.; Marschall, M.; Gariglio, M. et al. Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. J. Virol. 2014, 88, 6970-6982.
68. Giberson, A.N.; Davidson, A.R.; Parks, R.J. Chromatin structure of adenovirus DNA throughout infection. Nucleic Acids Res. 2012, 40, 2369-2376. [CrossRef] [PubMed]
69. Haruki, H.; Okuwaki, M.; Miyagishi, M.; Taira, K.; Nagata, K. Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J. Virol. 2006, 80, 794-801. [CrossRef] [PubMed]
70. Haruki, H.; Gyurcsik, B.; Okuwaki, M.; Nagata, K. Ternary complex formation between DNA-adenovirus core protein VII and TAF-I_/SET, an acidic molecular chaperone. FEBS Lett. 2003, 555, 521-527. [CrossRef]
71. Komatsu, T.; Haruki, H.; Nagata, K. Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res. 2011, 39, 889-901. [CrossRef] [PubMed]
72. Komatsu, T.; Dacheux, D.; Kreppel, F.; Nagata, K.; Wodrich, H. A Method for Visualization of Incoming Adenovirus Chromatin Complexes in Fixed and Living Cells. PLoS ONE 2015, 10, e0137102. [CrossRef] [PubMed]
73. Zheng, Y.; Stamminger, T.; Hearing, P. E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection. PLoS Pathog. 2016, 12, e1005415. [CrossRef] [PubMed]
74. Carvalho, T.; Seeler, J.S.; Ohman, K.; Jordan, P.; Pettersson, U.; Akusjärvi, G.; Carmo-Fonseca, M.; Dejean, A. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 1995, 131, 45-56. [CrossRef] [PubMed]
75. Ullman, A.J.; Hearing, P. Cellular Proteins PML and Daxx Mediate an Innate Antiviral Defense Antagonized by the Adenovirus E4 ORF3 Protein. J. Virol. 2008, 82, 7325-7335. [CrossRef] [PubMed]
76. Doucas, V.; Ishov, A.M.; Romo, A.; Juguilon, H.; Weitzman, M.D.; Evans, R.M.; Maul, G.G. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 1996, 10, 196-207. [CrossRef] [PubMed]
77. Rosa-Calatrava, M.; Puvion-Dutilleul, F.; Lutz, P.; Dreyer, D.; De Thé, H.; Chatton, B.; Kedinger, C. Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation. EMBO Rep. 2003, 4, 969-975. [CrossRef] [PubMed]
78. Schreiner, S.; Martinez, R.; Groitl, P.; Rayne, F.; Vaillant, R.; Wimmer, P.; Bossis, G.; Sternsdorf, T.; Marcinowski, L.; Ruzsics, Z. et al. Transcriptional Activation of the Adenoviral Genome Is Mediated by Capsid Protein VI. PLoS Pathog. 2012, 8, e1002549. [CrossRef] [PubMed]
79. Higginbotham, J.M.; O’Shea, C.C. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains. J. Virol. 2015, 89, 10260-10272. [CrossRef] [PubMed]
80. Schreiner, S.; Wimmer, P.; Sirma, H.; Everett, R.D.; Blanchette, P.; Groitl, P.; Dobner, T. Proteasome-Dependent Degradation of Daxx by the Viral E1B-55K Protein in Human Adenovirus-Infected Cells. J. Virol. 2010, 84, 7029-7038. [CrossRef] [PubMed]
81. Berscheminski, J.; Wimmer, P.; Brun, J.; Ip, W.H.; Groitl, P.; Horlacher, T.; Jaffray, E.; Hay, R.T.; Dobner, T.; Schreiner, S. Sp100 Isoform-Specific Regulation of Human Adenovirus 5 Gene Expression. J. Virol. 2014, 88, 6076-6092. [CrossRef] [PubMed]
82. Schreiner, S.; Burck, C.; Glass, M.; Groitl, P.; Wimmer, P.; Kinkley, S.; Mund, A.; Everett, R.D.; Dobner, T. Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res. 2013, 41, 3532-3550. [CrossRef] [PubMed]
83. Berscheminski, J.; Groitl, P.; Dobner, T.; Wimmer, P.; Schreiner, S. The Adenoviral Oncogene E1A-13S Interacts with a Specific Isoform of the Tumor Suppressor PML to Enhance Viral Transcription. J. Virol. 2012, 87, 965-977. [CrossRef] [PubMed]
84. Woodman, A.; Wright, J.; Atwan, Z.; Leppard, K.N. Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response. J. General Virol. 2016, 97, 1955-1967.
85. Schreiner, S.; Kinkley, S.; Bürck, C.; Mund, A.; Wimmer, P.; Schubert, T.; Groitl, P.; Will, H.; Dobner, T. SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection. PLoS Pathog. 2013, 9, e1003775. [CrossRef] [PubMed]
86. Tang, Q.; Bell, P.; Tegtmeyer, P.; Maul, G.G. Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J. Virol. 2000, 74, 9694-9700. [CrossRef] [PubMed]
87. Erickson, K.D.; Bouchet-Marquis, C.; Heiser, K.; Szomolanyi-Tsuda, E.; Mishra, R.; Lamothe, B.; Hoenger, A.; Garcea, R.L. Virion Assembly Factories in the Nucleus of Polyomavirus-Infected Cells. PLoS Pathog. 2012, 8, e1002630. [CrossRef] [PubMed]
88. Jiang, M.; Entezami, P.; Gamez, M.; Stamminger, T.; Imperiale, M.J. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. mBio 2011, 2, e00281-10. [CrossRef] [PubMed]
89. Day, P.M.; Baker, C.C.; Lowy, D.R.; Schiller, J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. USA 2004, 101, 14252-14257. [CrossRef] [PubMed]
90. Florin, L.; Schäfer, F.; Sotlar, K.; Streeck, R.E.; Sapp, M. Reorganization of Nuclear Domain 10 Induced by Papillomavirus Capsid Protein L2. Virology 2002, 295, 97-107. [CrossRef] [PubMed]
91. Stepp, W.H.; Meyers, J.M.; McBride, A.A. Sp100 Provides Intrinsic Immunity against Human Papillomavirus Infection. mBio 2013, 4, e00845-13. [CrossRef] [PubMed]
92. Cigno, Lo I.; De Andrea, M.; Borgogna, C.; Albertini, S.; Landini, M.M.; Peretti, A.; Johnson, K.E.; Chandran, B.; Landolfo, S.; Gariglio, M. The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. J. Virol. 2015, 89, 7506-7520. [CrossRef] [PubMed]
93. Lilley, C.E.; Chaurushiya, M.S.; Boutell, C.; Everett, R.D.; Weitzman, M.D. The Intrinsic Antiviral Defense to Incoming HSV-1 Genomes Includes Specific DNA Repair Proteins and Is Counteracted by the Viral Protein ICP0. PLoS Pathog. 2011, 7, e1002084. [CrossRef] [PubMed]
94. Karen, K.A.; Hearing, P. Adenovirus Core Protein VII Protects the Viral Genome from a DNA Damage Response at Early Times after Infection. J. Virol. 2011, 85, 4135-4142. [CrossRef] [PubMed]
95. Morrone, S.R.; Wang, T.; Constantoulakis, L.M.; Hooy, R.M.; Delannoy, M.J.; Sohn, J. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc. Natl. Acad. Sci. USA 2014, 111, E62-E71. [CrossRef] [PubMed]
96. Stratmann, S.A.; Morrone, S.R.; van Oijen, A.M.; Sohn, J. The innate immune sensor IFI16 recognizes foreign DNA in the nucleus by scanning along the duplex. Elife 2015, 4, 1-13. [CrossRef] [PubMed]
97. Scherer, M.; Reuter, N.; Wagenknecht, N.; Otto, V.; Sticht, H.; Stamminger, T. Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments. J. General Virol. 2013, 94, 1373-1384. [CrossRef] [PubMed]
98. Catez, F.; Picard, C.; Held, K.; Gross, S.; Rousseau, A.; Theil, D.; Sawtell, N.; Labetoulle, M.; Lomonte, P. HSV-1 Genome Subnuclear Positioning and Associations with Host-Cell PML-NBs and Centromeres Regulate LAT Locus Transcription during Latency in Neurons. PLoS Pathog. 2012, 8, e1002852. [CrossRef] [PubMed]
99. Bell, P.; Lieberman, P.M.; Maul, G.G. Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J. Virol. 2000, 74, 11800-11810. [CrossRef] [PubMed]
100. Sivachandran, N.; Sarkari, F.; Frappier, L. Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies. PLoS Pathog. 2008, 4, e1000170. [CrossRef] [PubMed]
101. Sivachandran, N.; Wang, X.; Frappier, L. Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection. J. Virol. 2012, 86, 6146-6158. [CrossRef] [PubMed]
102. Izumiya, Y.; Kobayashi, K.; Kim, K.Y.; Pochampalli, M.; Izumiya, C.; Shevchenko, B.; Wang, D.-H.; Huerta, S.B.; Martinez, A.; Campbell, M. et al. Kaposi’s Sarcoma-Associated Herpesvirus K-Rta Exhibits SUMO-Targeting Ubiquitin Ligase (STUbL) Like Activity and Is Essential for Viral Reactivation. PLoS Pathog. 2013, 9, e1003506. [CrossRef] [PubMed]
103. Günther, T.; Schreiner, S.; Dobner, T.; Tessmer, U.; Grundhoff, A. Influence of ND10 Components on Epigenetic Determinants of Early KSHV Latency Establishment. PLoS Pathog. 2014, 10, e1004274. [CrossRef] [PubMed]
104. Wagenknecht, N.; Reuter, N.; Scherer, M.; Reichel, A.; Müller, R.; Stamminger, T. Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1. Viruses 2015, 7, 2884-2907. [CrossRef] [PubMed]
105. Roy, A.; Dutta, D.; Iqbal, J.; Pisano, G.; Gjyshi, O.; Ansari, M.A.; Kumar, B.; Chandran, B. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency. J. Virol. 2016, 90, 8822-8841. [CrossRef] [PubMed]